ask="12.25"
ask_size="900"
average_daily_volume="10142"
bid="5.15"
bid_size="100"
book_value="2.91"
change="-0.09"
change_from_200_day_moving_average="-0.71"
change_from_50_day_moving_average="-0.88"
change_from_52_week_high="-4.68"
change_From_52_week_low="2.05"
change_in_percent="-0.96%"
close="9.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.64"
ebitda="0.00"
eps_estimate_current_year="-1.99"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-1.85"
ex_dividend_date="N/A"
float_shares="3574000"
high="9.37"
high_52_weeks="13.98"
last_trade_date="3/1/2017"
last_trade_price="9.30"
last_trade_size="100"
last_trade_time="4:00pm"
low="9.20"
low_52_weeks="7.25"
market_capitalization="86.21M"
moving_average_200_day="10.01"
moving_average_50_day="10.18"
name="Gemphire Therapeutics Inc."
notes="N/A"
one_year_target_price="19.75"
open="9.31"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-7.11%"
percent_change_from_50_day_moving_average="-8.68%"
percent_change_from_52_week_high="-33.48%"
percent_change_from_52_week_low="+28.28%"
previous_close="9.39"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.23"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9270000"
short_ratio="0.73"
stock_exchange="NGM"
symbol="GEMP"
volume="5923"
weeks_range_52="7.25 - 13.98"
